IL135943A0 - Hyperthermic inducible expression vectors for gene theraphy and methods of use thereof - Google Patents
Hyperthermic inducible expression vectors for gene theraphy and methods of use thereofInfo
- Publication number
- IL135943A0 IL135943A0 IL13594398A IL13594398A IL135943A0 IL 135943 A0 IL135943 A0 IL 135943A0 IL 13594398 A IL13594398 A IL 13594398A IL 13594398 A IL13594398 A IL 13594398A IL 135943 A0 IL135943 A0 IL 135943A0
- Authority
- IL
- Israel
- Prior art keywords
- hyperthermic
- methods
- expression vectors
- inducible expression
- gene theraphy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6408897P | 1997-11-03 | 1997-11-03 | |
PCT/US1998/023387 WO1999023216A2 (en) | 1997-11-03 | 1998-11-03 | Hyperthermic inducible expression vectors for gene therapy and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IL135943A0 true IL135943A0 (en) | 2001-05-20 |
Family
ID=22053477
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13594398A IL135943A0 (en) | 1997-11-03 | 1998-11-03 | Hyperthermic inducible expression vectors for gene theraphy and methods of use thereof |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1029041A2 (en) |
JP (1) | JP2001521740A (en) |
KR (1) | KR20010031762A (en) |
CN (1) | CN1299411A (en) |
AU (1) | AU1377299A (en) |
BR (1) | BR9813917A (en) |
CA (1) | CA2308575A1 (en) |
IL (1) | IL135943A0 (en) |
WO (1) | WO1999023216A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19951765A1 (en) * | 1999-10-27 | 2001-05-03 | Thomas Schweder | Host-vector systems for the overproduction of thermolabile enzymes in psychrophilic organisms |
US6579522B1 (en) | 2000-06-27 | 2003-06-17 | Genvec, Inc. | Replication deficient adenoviral TNF vector |
CA2423833C (en) * | 2000-09-26 | 2011-02-22 | Emory University | Viruses targeted to hypoxic cells and tissues |
US7285414B2 (en) | 2000-09-26 | 2007-10-23 | Emory University | Viruses targeted to hypoxic cells and tissues |
US20030086903A1 (en) | 2001-11-02 | 2003-05-08 | Genvec, Inc. | Therapeutic regimen for treating cancer |
HUE025872T2 (en) | 2002-06-18 | 2016-05-30 | Eisai R&D Man Co Ltd | Primary cultured adipocytes for gene therapy |
AU2003278079A1 (en) * | 2002-10-14 | 2004-05-04 | Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung | Proteins involved in the regulation of energy homeostasis |
JP2008048601A (en) * | 2004-06-15 | 2008-03-06 | Nippon Kosei Kagaku Kenkyusho:Kk | Method for producing therapeutically useful product and system |
WO2006116789A2 (en) * | 2005-05-03 | 2006-11-09 | Veterinärmedizinische Universität Wien | Permeable capsules |
JP2010540534A (en) * | 2007-09-28 | 2010-12-24 | イントレキソン コーポレーション | Therapeutic gene switch constructs and bioreactors for the expression of biotherapeutic molecules and uses thereof |
CN103667345B (en) * | 2013-12-02 | 2015-10-28 | 东南大学 | A kind of Antioncogene magnetic composite nano particle and preparation method |
WO2017133175A1 (en) * | 2016-02-04 | 2017-08-10 | Nanjing Legend Biotech Co., Ltd. | Engineered mammalian cells for cancer therapy |
CN108913661A (en) * | 2018-06-22 | 2018-11-30 | 安徽 | A kind of preparation and extracting method of human research's candidate stem cell |
CN114317588B (en) * | 2020-09-29 | 2023-06-27 | 中国农业科学院生物技术研究所 | Accurate methylation regulation and control return circuit of crop high temperature response formula genome |
IT202200000788A1 (en) * | 2022-01-19 | 2023-07-19 | Bruno Cell S R L | Temperature-sensitive induction of the myogenic and/or adipogenic program in cells producing muscle and/or adipose tissue |
CN116536349B (en) * | 2023-05-22 | 2024-02-20 | 安徽农业大学 | Application of soybean GmMLP34 gene in regulation and control of high temperature resistance of plants |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3991770A (en) * | 1974-01-24 | 1976-11-16 | Leveen Harry H | Method for treating benign and malignant tumors utilizing radio frequency, electromagnetic radiation |
EP0299127A1 (en) * | 1987-07-16 | 1989-01-18 | IntraCel Corporation | A method for the expression of recombinant genes under stimulation from an inducively expressed activator protein |
EP0455424A3 (en) * | 1990-05-02 | 1992-04-29 | Merck & Co. Inc. | Mammalian inducible promoter cascade system |
FR2717187B1 (en) * | 1994-03-10 | 1996-05-31 | Transgene Sa | Combined use of two expression cassettes for the production of a protein of interest. |
-
1998
- 1998-11-03 BR BR9813917-7A patent/BR9813917A/en not_active Application Discontinuation
- 1998-11-03 JP JP2000519075A patent/JP2001521740A/en active Pending
- 1998-11-03 CA CA002308575A patent/CA2308575A1/en not_active Abandoned
- 1998-11-03 KR KR1020007004827A patent/KR20010031762A/en not_active Application Discontinuation
- 1998-11-03 AU AU13772/99A patent/AU1377299A/en not_active Abandoned
- 1998-11-03 IL IL13594398A patent/IL135943A0/en unknown
- 1998-11-03 EP EP98957538A patent/EP1029041A2/en not_active Withdrawn
- 1998-11-03 CN CN98812752A patent/CN1299411A/en active Pending
- 1998-11-03 WO PCT/US1998/023387 patent/WO1999023216A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2308575A1 (en) | 1999-05-14 |
EP1029041A2 (en) | 2000-08-23 |
JP2001521740A (en) | 2001-11-13 |
CN1299411A (en) | 2001-06-13 |
AU1377299A (en) | 1999-05-24 |
BR9813917A (en) | 2001-10-30 |
WO1999023216A3 (en) | 1999-08-05 |
WO1999023216A2 (en) | 1999-05-14 |
KR20010031762A (en) | 2001-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL135943A0 (en) | Hyperthermic inducible expression vectors for gene theraphy and methods of use thereof | |
EP1037911A4 (en) | Anti-pathogen system and methods of use thereof | |
AU1194802A (en) | DNA expression vectors and methods of use | |
HUP0003852A3 (en) | Use of highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias | |
PL321201A1 (en) | Derivatives of 4-hydroxypiepridine, method of obtaining them and therapeutic agents containing such derivatives | |
PL110099U1 (en) | Pair of hairdresser's scisors | |
IL123716A0 (en) | New therapeutic combinations of mirtazepine and an antipsychotic agent | |
HUP9902655A3 (en) | Pharmaceutical composition of hedgehog proteins and use thereof | |
GB2327190B (en) | Process for the preparation of depilatory compositions and their use | |
EP0923642A4 (en) | Active survival domains of igf-ir and methods of use | |
ZA955292B (en) | Medical use of bromelain | |
AU4553793A (en) | Use of p97 and iron binding proteins as diagnostic and therapeutic agents | |
HK1031128A1 (en) | Jnk3 modulators and methods of use | |
AU6450398A (en) | Sr-bi regulatory sequences and therapeutic methods of use | |
IL129593A0 (en) | Novel constructs and vectors for the targeted and inducible expression of genes | |
EP1037669A4 (en) | Therapeutic use of lentiviral vectors | |
HUP0000845A3 (en) | Process for the preparation of iodinated contrast agents and intermediates therefor | |
HUP9800146A3 (en) | Thalidomide-derivatives and use of them | |
AU5293198A (en) | Promoter of the human endoglin gene and its use | |
IL126757A0 (en) | Regulation of gene expression through manipulation of mRNA splicing and its uses | |
GB9800476D0 (en) | Cosmetic composition for the treatment of the hair and/or the body | |
EP1070141A4 (en) | Immediate early genes and methods of use therefor | |
AU2743097A (en) | Simplified use of 5' ends of rnas for cloning and cdna library construction | |
EP1005360A4 (en) | Antioxidant protein 2, gene and methods of use therefor | |
EP1015559A4 (en) | Human regeneration-associated serpin-1 (rasp-1) and methods of use |